These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 24335316

  • 21. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5.
    Zwick MB, Komori HK, Stanfield RL, Church S, Wang M, Parren PW, Kunert R, Katinger H, Wilson IA, Burton DR.
    J Virol; 2004 Mar; 78(6):3155-61. PubMed ID: 14990736
    [Abstract] [Full Text] [Related]

  • 22. Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface.
    Rujas E, Caaveiro JM, Partida-Hanon A, Gulzar N, Morante K, Apellániz B, García-Porras M, Bruix M, Tsumoto K, Scott JK, Jiménez MÁ, Nieva JL.
    Sci Rep; 2016 Dec 01; 6():38177. PubMed ID: 27905530
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V, Torralba J, Rujas E, Nieva JL, Domene C, Apellaniz B.
    Biochim Biophys Acta Biomembr; 2018 Jun 01; 1860(6):1259-1271. PubMed ID: 29477358
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
    Soto C, Ofek G, Joyce MG, Zhang B, McKee K, Longo NS, Yang Y, Huang J, Parks R, Eudailey J, Lloyd KE, Alam SM, Haynes BF, NISC Comparative Sequencing Program, Mullikin JC, Connors M, Mascola JR, Shapiro L, Kwong PD.
    PLoS One; 2016 Jun 01; 11(6):e0157409. PubMed ID: 27299673
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Crystal structure of the complex between the F(ab)' fragment of the cross-neutralizing anti-HIV-1 antibody 2F5 and the F(ab) fragment of its anti-idiotypic antibody 3H6.
    Bryson S, Julien JP, Isenman DE, Kunert R, Katinger H, Pai EF.
    J Mol Biol; 2008 Oct 17; 382(4):910-9. PubMed ID: 18692506
    [Abstract] [Full Text] [Related]

  • 30. A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1.
    Lai RP, Hock M, Radzimanowski J, Tonks P, Hulsik DL, Effantin G, Seilly DJ, Dreja H, Kliche A, Wagner R, Barnett SW, Tumba N, Morris L, LaBranche CC, Montefiori DC, Seaman MS, Heeney JL, Weissenhorn W.
    J Biol Chem; 2014 Oct 24; 289(43):29912-26. PubMed ID: 25160627
    [Abstract] [Full Text] [Related]

  • 31. Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins.
    Wang P, Yang X.
    J Virol; 2010 Jul 24; 84(14):7114-23. PubMed ID: 20463081
    [Abstract] [Full Text] [Related]

  • 32. Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation.
    Alam SM, Liao HX, Dennison SM, Jaeger F, Parks R, Anasti K, Foulger A, Donathan M, Lucas J, Verkoczy L, Nicely N, Tomaras GD, Kelsoe G, Chen B, Kepler TB, Haynes BF.
    J Virol; 2011 Nov 24; 85(22):11725-31. PubMed ID: 21917975
    [Abstract] [Full Text] [Related]

  • 33. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
    Cerutti N, Loredo-Varela JL, Caillat C, Weissenhorn W.
    Curr Opin HIV AIDS; 2017 May 24; 12(3):250-256. PubMed ID: 28422789
    [Abstract] [Full Text] [Related]

  • 34. Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41.
    Dennison SM, Sutherland LL, Jaeger FH, Anasti KM, Parks R, Stewart S, Bowman C, Xia SM, Zhang R, Shen X, Scearce RM, Ofek G, Yang Y, Kwong PD, Santra S, Liao HX, Tomaras G, Letvin NL, Chen B, Alam SM, Haynes BF.
    PLoS One; 2011 May 24; 6(11):e27824. PubMed ID: 22140469
    [Abstract] [Full Text] [Related]

  • 35. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
    Shen X, Dennison SM, Liu P, Gao F, Jaeger F, Montefiori DC, Verkoczy L, Haynes BF, Alam SM, Tomaras GD.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5972-7. PubMed ID: 20231447
    [Abstract] [Full Text] [Related]

  • 36. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface.
    Song L, Sun ZY, Coleman KE, Zwick MB, Gach JS, Wang JH, Reinherz EL, Wagner G, Kim M.
    Proc Natl Acad Sci U S A; 2009 Jun 02; 106(22):9057-62. PubMed ID: 19458040
    [Abstract] [Full Text] [Related]

  • 37. In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth.
    Shen X, Parks RJ, Montefiori DC, Kirchherr JL, Keele BF, Decker JM, Blattner WA, Gao F, Weinhold KJ, Hicks CB, Greenberg ML, Hahn BH, Shaw GM, Haynes BF, Tomaras GD.
    J Virol; 2009 Apr 02; 83(8):3617-25. PubMed ID: 19193787
    [Abstract] [Full Text] [Related]

  • 38. Passively transmitted gp41 antibodies in babies born from HIV-1 subtype C-seropositive women: correlation between fine specificity and protection.
    Diomede L, Nyoka S, Pastori C, Scotti L, Zambon A, Sherman G, Gray CM, Sarzotti-Kelsoe M, Lopalco L.
    J Virol; 2012 Apr 02; 86(8):4129-38. PubMed ID: 22301151
    [Abstract] [Full Text] [Related]

  • 39. HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies.
    Wang J, Tong P, Lu L, Zhou L, Xu L, Jiang S, Chen YH.
    PLoS One; 2011 Mar 31; 6(3):e18233. PubMed ID: 21483871
    [Abstract] [Full Text] [Related]

  • 40. Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.
    Bradley T, Trama A, Tumba N, Gray E, Lu X, Madani N, Jahanbakhsh F, Eaton A, Xia SM, Parks R, Lloyd KE, Sutherland LL, Scearce RM, Bowman CM, Barnett S, Abdool-Karim SS, Boyd SD, Melillo B, Smith AB, Sodroski J, Kepler TB, Alam SM, Gao F, Bonsignori M, Liao HX, Moody MA, Montefiori D, Santra S, Morris L, Haynes BF.
    EBioMedicine; 2016 Oct 31; 12():196-207. PubMed ID: 27612593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.